Skip to content

Pulsar-18 T3 4/80/135Recalls & reported problems

Biotronik AG · Class 3 · Implant

All models of Pulsar-18 T3 (52)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07640130446793), received between Jan 26, 2021 and Jan 26, 2021 — classified as 1 malfunction.

The most frequently reported specific device problem is “Premature Activation” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Premature Activation1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJan 26, 2021Premature Activation; Premature Activation

    A PULSAR-18 T3 STENT SYSTEM WAS CHOSEN FOR TREATMENT IN THE SFA. THE STENT RELEASED INSIDE THE INTRODUCER SHEATH, WAS WITHDRAWN AND NOT IMPLANTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 11233168 ↗

Other STENT, SUPERFICIAL FEMORAL ARTERY devices

All STENT, SUPERFICIAL FEMORAL ARTERY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page